PRODUCT DETAIL

Candesartan HCT Swyssi 8 mg/12,5 mg

Code

5161B

MA number

58/0309/15-S

Product Form:

tbl 30x8 mg/12,5 mg (blis.OPA/Al/PVC/Al)

MA Status:

D - Marketing Authorisation valid for an unlimited period

Type of procedure:

Decentralised

Therapeutic Class:

58 - HYPOTENSIVA

ATC:

C	CARDIOVASCULAR SYSTEM
C09	AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
C09D	ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
C09DA	Angiotensin II antagonists and diuretics
C09DA06	Candesartan and diuretics

Shelf life:

Container:

blister OPA/Al/PVC/Al

Route of admin.:

Oral use

Prescription Status:	Medicinal product subject to medical prescription.
Legal basis:	Article 10(3) hybrid application
MA issued:	03.08.2015
SPC:	SPC_Candesartan HCT Swyssi_tbl_03_2024.pdf
PIL:	PIL_Candesartan HCT Swyssi_tbl_03_2024.pdf
Safety feature	Yes
Data update:	31.12.2021